Research Topics
| Jf SimardSummaryAffiliation: Harvard University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Lifestyle factors, autoimmune disease and family history in prognosis of non-hodgkin lymphoma overall and subtypesJulia F Simard
Department of Medicine, Clinical Epidemiology Unit, Karolinska Institutet, Stockholm, Sweden
Int J Cancer 132:2659-66. 2013..Further investigations are needed to determine how these factors should be incorporated into clinical prognostic assessment...- Ten years with biologics: to whom do data on effectiveness and safety apply?Julia F Simard
Department of Medicine, Clinical Epidemiology Unit, T2, Karolinska Institutet, Karolinska University Hospital, 171 76 Stockholm, Sweden
Rheumatology (Oxford) 50:204-13. 2011..The aim of this study was to assess the extent to which contemporary patients who start or switch biologic therapies are comparable with those patients who gave rise to the currently available data on effectiveness and safety... - Juvenile idiopathic arthritis and risk of cancer: a nationwide cohort studyJ F Simard
Karolinska Institutet, Stockholm, Sweden
Arthritis Rheum 62:3776-82. 2010..Therefore, the aim of this study was to determine the risk of cancer in patients with JIA as compared with that in the general population... 
Validity of self-report of infections in a longitudinal cohort of patients with rheumatoid arthritis differs by source of report and infection severityJulia F Simard
Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA
J Clin Epidemiol 63:1358-62. 2010..We evaluated and compared the validity of patients' and rheumatologists' reports of infection with those confirmed by medical record review...- Early life factors and adult-onset rheumatoid arthritisJulia F Simard
Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA
J Rheumatol 37:32-7. 2010..We investigated the association of preterm birth and being breastfed with the incidence of rheumatoid arthritis (RA) in 2 large prospective cohorts... - Exposure to maternal smoking and incident SLE in a prospective cohort studyJ F Simard
Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
Lupus 18:431-5. 2009..0, 95% CI: 0.8 to 1.3) in combined analyses. Early-life exposure to cigarette smoke due to mothers' or fathers' smoking was not associated with increased risk of adult-onset SLE in women... - Perinatal factors and adult-onset lupusJulia F Simard
Department of Epidemiology, Harvard University School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA
Arthritis Rheum 59:1155-61. 2008..Therefore, we evaluated the role of birth weight, being breastfed, and preterm birth on the incidence of SLE in participants in the Nurses' Health Study (NHS) and the Nurses' Health Study II (NHSII)... 
Prevalent rheumatoid arthritis and diabetes among NHANES III participants aged 60 and olderJulia F Simard
Department of Epidemiology, Harvard School of Public Health, and the Cardiovascular Epidemiology Research Unit, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
J Rheumatol 34:469-73. 2007..This study examines the cross-sectional association between prevalent rheumatoid arthritis (RA) and diabetes among noninstitutionalized US civilians aged >or= 60 years between 1988 and 1994...- What can epidemiology tell us about systemic lupus erythematosus?J F Simard
Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
Int J Clin Pract 61:1170-80. 2007..While epidemiologic research has contributed an enormous amount to our understanding of the disease and its pathogenesis, there are many more avenues of epidemiologic research that deserve to be pursued... - Exposure to cigarette smoke in utero: comparison of reports from mother and daughterJulia F Simard
Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
Epidemiology 19:628-33. 2008..To study the role of in utero smoking exposure in offsprings' adult health outcomes, it may be necessary to rely upon reports by the offspring themselves... - Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics RegisterM Neovius
Department of Medicine, Karolinska Institutet, SE 171 76 Stockholm, Sweden
Ann Rheum Dis 70:516-9. 2011..To determine coverage and generalisability of data in the Swedish Biologics Register ARTIS... - The effectiveness of anti-tumor necrosis factor therapy in preventing progressive radiographic joint damage in rheumatoid arthritis: a population-based studyAxel Finckh
Robert B Brigham Atthritis and Musculoskeletal Diseases Clinical Research Center, Brigham and Women s Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
Arthritis Rheum 54:54-9. 2006..The 3 strategies were infliximab with concomitant disease-modifying antirheumatic drugs (DMARDs), etanercept with concomitant DMARDs, and etanercept alone... - Small-area variations in sales of TNF inhibitors in Sweden between 2000 and 2009M Neovius
Department of Medicine, Clinical Epidemiology Unit, Karolinska Institutet, Stockholm
Scand J Rheumatol 40:8-15. 2011..To measure small-area variations in sales per capita of tumour necrosis factor (TNF) inhibitors... - Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort studyJohanna Gustafsson
Rheumatology Unit, Department of Medicine Karolinska University Hospital, Solna, Karolinska Institutet, SE 171 76 Stockholm, Sweden
Arthritis Res Ther 11:R186. 2009..e. clinically important cardiovascular events (CVE). We investigated the impact of traditional and lupus associated risk factors for the first ever CVE in a longitudinal cohort of SLE patients... - A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosusElisabet Svenungsson
Rheumatology Unit, Department of Medicine, Karolinska University Hospital, Solna, SE 17176 Stockholm, Sweden
Ann Rheum Dis 69:834-40. 2010.... - The large print giveth and the small print taketh away: preemptive treatment of serologically active, clinically quiet systemic lupus erythematosusMatthew H Liang
Arthritis Rheum 54:3378-80. 2006